Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2001) | Total Docs. (3years) | Total Refs. (2001) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2001) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126 | Pharmaceutical Visions | journal | 0.100 Q4 | 2 | 28 | 153 | 70 | 0 | 57 | 0.00 | 2.50 |  |
| 125 | DARU, Journal of Pharmaceutical Sciences | journal | 0.102 Q4 | 58 | 19 | 9 | 333 | 0 | 9 | 0.00 | 17.53 | |
| 124 | Manufacturing Chemist | trade journal | 0.104 Q4 | 6 | 906 | 791 | 137 | 9 | 141 | 0.01 | 0.15 | |
| 123 | Progress in Pharmaceutical and Biomedical Analysis | book series | 0.106 Q4 | 8 | 0 | 49 | 0 | 2 | 47 | 0.04 | 0.00 | |
| 122 | Journal of Applied Therapeutic Research | journal | 0.117 Q4 | 8 | 0 | 51 | 0 | 3 | 51 | 0.04 | 0.00 | |
| 121 | Pharmacy in Practice | journal | 0.119 Q4 | 6 | 25 | 70 | 141 | 5 | 40 | 0.08 | 5.64 | |
| 120 | Toxicology Mechanisms and Methods | journal | 0.121 Q4 | 55 | 21 | 118 | 610 | 36 | 114 | 0.30 | 29.05 | |
| 119 | Cutaneous and Ocular Toxicology | journal | 0.124 Q4 | 37 | 27 | 128 | 1630 | 17 | 109 | 0.10 | 60.37 | |
| 118 | Pharmaceutical News | journal | 0.124 Q3 | 11 | 72 | 29 | 894 | 6 | 24 | 0.21 | 12.42 | |
| 117 | Quality Assurance Journal | journal | 0.139 Q3 | 11 | 25 | 57 | 118 | 3 | 52 | 0.09 | 4.72 | |
| 116 | Pharmaceutical Medicine | journal | 0.142 Q4 | 25 | 60 | 196 | 684 | 44 | 129 | 0.24 | 11.40 | |
| 115 | IDrugs : the investigational drugs journal | journal | 0.159 Q3 | 39 | 54 | 310 | 4189 | 71 | 306 | 0.21 | 77.57 | |
| 114 | Journal of Clinical Research | journal | 0.161 Q3 | 12 | 10 | 56 | 233 | 17 | 56 | 0.25 | 23.30 | |
| 113 | Prescribers' Journal | journal | 0.161 Q3 | 6 | 0 | 110 | 0 | 24 | 80 | 0.30 | 0.00 | |
| 112 | Pharmacology Reviews and Communications | journal | 0.165 Q3 | 9 | 26 | 43 | 777 | 15 | 43 | 0.24 | 29.88 | |
| 111 | Drugs in R and D | journal | 0.170 Q3 | 54 | 0 | 240 | 0 | 76 | 240 | 0.32 | 0.00 | |
| 110 | Toxic Substance Mechanisms | journal | 0.172 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 109 | Comments on Toxicology | journal | 0.178 Q4 | 13 | 20 | 44 | 789 | 12 | 30 | 0.48 | 39.45 | |
| 108 | Toxicology Methods | journal | 0.178 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 107 | Pharmacology and Toxicology, Supplement | journal | 0.179 Q3 | 7 | 0 | 47 | 0 | 16 | 46 | 0.27 | 0.00 | |
| 106 | Paediatric and Perinatal Drug Therapy | journal | 0.183 Q3 | 20 | 18 | 38 | 381 | 15 | 34 | 0.41 | 21.17 | |
| 105 | Current Opinion in Investigational Drugs | journal | 0.185 Q3 | 83 | 36 | 0 | 1888 | 0 | 0 | 0.00 | 52.44 | |
| 104 | Current Opinion in Anti-inflammatory and Immunomodulatory Investigational Drugs | journal | 0.220 Q3 | 5 | 0 | 35 | 0 | 15 | 30 | 0.43 | 0.00 | |
| 103 | Pharmacy and Pharmacology Communications | journal | 0.225 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 102 | British Journal of Clinical Pharmacology, Supplement | journal | 0.231 Q2 | 33 | 18 | 12 | 649 | 25 | 11 | 0.00 | 36.06 | |
| 101 | Pharmaceutical Journal | journal | 0.232 Q2 | 28 | 901 | 1036 | 1740 | 114 | 480 | 0.11 | 1.93 | |
| 100 | Expert Opinion on Emerging Drugs | journal | 0.233 Q3 | 54 | 23 | 70 | 2173 | 60 | 68 | 0.89 | 94.48 | |
| 99 | BioDrugs | journal | 0.237 Q3 | 79 | 70 | 230 | 4783 | 142 | 218 | 0.58 | 68.33 | |
| 98 | Expert Opinion on Therapeutic Targets | journal | 0.254 Q3 | 106 | 47 | 135 | 5636 | 70 | 135 | 0.75 | 119.91 | |
| 97 | Mathematical Medicine and Biology | journal | 0.260 Q3 | 49 | 19 | 64 | 472 | 38 | 64 | 0.41 | 24.84 | |
| 96 | Reviews in Contemporary Pharmacotherapy | journal | 0.261 Q3 | 18 | 6 | 79 | 1445 | 107 | 79 | 2.28 | 240.83 | |
| 95 | Journal of Pharmacy and Pharmacology | journal | 0.264 Q2 | 137 | 213 | 1792 | 6060 | 1028 | 1758 | 0.55 | 28.45 | |
| 94 | ChemMedChem | journal | 0.273 Q2 | 119 | 157 | 351 | 2845 | 250 | 348 | 0.75 | 18.12 | |
| 93 | Adverse Drug Reactions and Toxicological Reviews | journal | 0.275 Q3 | 25 | 21 | 54 | 738 | 52 | 28 | 0.93 | 35.14 | |
| 92 | Drug Delivery | journal | 0.290 Q2 | 95 | 29 | 97 | 902 | 62 | 97 | 0.71 | 31.10 | |
| 91 | Acta Pharmacologica Sinica | journal | 0.294 Q3 | 117 | 207 | 589 | 3661 | 357 | 588 | 0.67 | 17.69 | |
| 90 | Pharmaceutical Biology | journal | 0.297 Q2 | 88 | 97 | 232 | 2172 | 93 | 229 | 0.35 | 22.39 | |
| 89 | Biopharmaceutics and Drug Disposition | journal | 0.299 Q2 | 65 | 36 | 183 | 1661 | 147 | 181 | 0.86 | 46.14 | |
| 88 | Expert Opinion on Pharmacotherapy | journal | 0.301 Q3 | 93 | 168 | 105 | 11843 | 123 | 104 | 1.17 | 70.49 | |
| 87 | International Journal of Cosmetic Science | journal | 0.314 Q2 | 77 | 42 | 116 | 838 | 82 | 113 | 0.67 | 19.95 | |
| 86 | Journal of Labelled Compounds and Radiopharmaceuticals | journal | 0.323 Q3 | 54 | 100 | 704 | 1831 | 368 | 702 | 0.51 | 18.31 | |
| 85 | Advances in Antiviral Drug Design | book series | 0.330 Q2 | 12 | 0 | 7 | 0 | 7 | 5 | 1.00 | 0.00 | |
| 84 | Toxicology in Vitro | journal | 0.332 Q3 | 125 | 96 | 245 | 2613 | 242 | 244 | 0.93 | 27.22 | |
| 83 | Toxin Reviews | journal | 0.348 Q3 | 54 | 15 | 90 | 859 | 63 | 87 | 0.81 | 57.27 | |
| 82 | Drug Design and Discovery | journal | 0.350 Q3 | 20 | 1 | 66 | 0 | 55 | 62 | 0.83 | 0.00 | |
| 81 | Tumor Targeting | journal | 0.357 Q2 | 10 | 0 | 54 | 0 | 62 | 52 | 1.44 | 0.00 | |
| 80 | ATLA Alternatives to Laboratory Animals | journal | 0.367 Q3 | 65 | 65 | 188 | 1402 | 177 | 163 | 0.78 | 21.57 | |
| 79 | Clinical Toxicology | journal | 0.369 Q3 | 108 | 88 | 323 | 1775 | 460 | 249 | 1.64 | 20.17 | |
| 78 | Autonomic and Autacoid Pharmacology | journal | 0.376 Q2 | 24 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 77 | SAR and QSAR in Environmental Research | journal | 0.376 Q3 | 54 | 45 | 49 | 66 | 83 | 49 | 1.94 | 1.47 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data